Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Board of Scientific Counselors, National Center for Injury Prevention and Control (BSC, NCIPC or Board). This meeting is partially open to the public. There will be 15 minutes allotted for public comments at the end of the open session from 1:00 p.m. to 1:15 p.m., EDT.
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 145 (Friday, July 29, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 145 (Friday, July 29, 2022)]
[Notices]
[Pages 45775-45776]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-16335]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Injury
Prevention and Control (BSC, NCIPC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Injury Prevention and Control (BSC, NCIPC or
Board). This meeting is partially open to the public. There will be 15
minutes allotted for public comments at the end of the open session
from 1:00 p.m. to 1:15 p.m., EDT.
DATES: The meeting will be held on August 23, 2022, from 11:00 a.m. to
1:15 p.m., EDT (OPEN); and from 1:30 p.m. to 4:30 p.m., EDT (CLOSED).
ADDRESSES: Open Session: Webinar, Atlanta, Georgia. All participants
must register using the link provided to attend the open meeting:
<a href="https://dceproductions.zoom.us/meeting/register/tZYtd-iurzIvHNDz3Nb2Kl4NqksXHAhcwZnV">https://dceproductions.zoom.us/meeting/register/tZYtd-iurzIvHNDz3Nb2Kl4NqksXHAhcwZnV</a>.
Closed Session: Teleconference.
FOR FURTHER INFORMATION CONTACT: Arlene Greenspan, DrPH, MPH, PT,
Associate Director for Science, NCIPC, CDC, 4770 Buford Highway, NE,
Mailstop S-1069, Atlanta, Georgia 30341; Telephone: (770) 488-1279;
Email: <a href="/cdn-cgi/l/email-protection#e8868b81988b8a9b8ba88b8c8bc68f879e"><span class="__cf_email__" data-cfemail="a3cdc0cad3c0c1d0c0e3c0c7c08dc4ccd5">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Portions of the meeting referenced above
will be closed to the public in accordance with provisions set forth in
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of
the Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer,
[[Page 45776]]
CDC, pursuant to Public Law 92-463 (5 U.S.C. app. 2).
Purpose: The Board will: (1) conduct, encourage, cooperate with,
and assist other appropriate public health authorities, scientific
institutions, and scientists in the conduct of research,
investigations, experiments, demonstrations, and studies relating to
the causes and strategies related to the prevention of injury and
violence; (2) assist States and other entities in preventing
intentional and unintentional injuries and in promoting health and
well-being; and (3) conduct and assist in research and control
activities related to injury.
The BSC, NCIPC makes recommendations regarding policies,
strategies, objectives, and priorities, and reviews progress toward
injury and violence prevention. The Board provides advice on the
appropriate balance of intramural and extramural research, and guidance
on the needs, structure, progress, and performance of intramural
programs. The Board also provides guidance on extramural scientific
program matters, including the: (1) review of extramural research
concepts for funding opportunity announcements; (2) conduct of
Secondary Peer Review of extramural research grant applications,
cooperative agreement applications, and contract applications received
in response to funding opportunity announcements as they relate to the
Center's programmatic balance and mission; (3) submission of secondary
review recommendations to the Center Director of applications to be
considered for funding support; (4) review of research portfolios; and
(5) review of program proposals.
Matters To Be Considered: The open session of the meeting will
include discussions on an NCIPC update on Motor Vehicle Injury
Prevention Research Priorities and on an NCIPC presentation on new
research priorities in Drowning Prevention Research. The closed session
of the meeting will focus on the Secondary Peer Review of extramural
research grant applications received in response to four (4) Notices of
Funding Opportunities (NOFOs): (1) RFA-CE-22-009--``Rigorous Evaluation
of Community-Level Substance Use and Overdose Prevention Frameworks
that Incorporate ACE-Related Prevention Strategies''; (2) RFA-CE-22-
010--``Rigorous Evaluation of Strategies to Prevent Overdose through
Linking People with Illicit Substance Use Disorders to Recovery Support
Services''; (3) RFA-CE-22-011--``Understanding Polydrug Use Risk and
Protective Factors, Patterns, and Trajectories to Prevent Drug
Overdose''; and (4) RFA-CE-22-013--``Rigorous Evaluation of Community-
Centered Approaches for the Prevention of Community Violence.'' Agenda
items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-16335 Filed 7-28-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.